Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioid modulation of ventral pallidal inputs.

T C Napier1, I Mitrovic

  • 1Department of Pharmacology and Experimental Therapeutics, Loyola University Chicago, Maywood, Illinois 60153, USA. cnapier@luc.edu

Annals of the New York Academy of Sciences
|July 23, 1999
PubMed
Summary

Opioid receptors in the ventral pallidum selectively modulate brain signals. Mu opioid receptor agonists enhance glutamate inputs while reducing dopamine and GABA signals, impacting behavior and potentially contributing to drug craving.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to: In Utero Exposure to Anesthetics Alters Neuronal Migration Pattern in Developing Cerebral Cortex and Causes Postnatal Behavioral Deficits in Rats.

Cerebral cortex (New York, N.Y. : 1991)·2020
Same author

In utero Exposure to Anesthetics Alters Neuronal Migration Pattern in Developing Cerebral Cortex and Causes Postnatal Behavioral Deficits in Rats.

Cerebral cortex (New York, N.Y. : 1991)·2019
Same author

Pricing and Reimbursement Analysis of Bacillus Calmette-Guérin (BCG) Immunotherapy for Bladder Cancer.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

mGluR5 is necessary for maintenance of methamphetamine-induced associative learning.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2012
Same author

Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.

Behavioural brain research·2012
Same author

Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats.

Drug and alcohol dependence·2006

Area of Science:

  • Neuroscience
  • Neuropharmacology
  • Behavioral Neuroscience

Background:

  • The ventral pallidum (VP) is a key node for information relay and processing.
  • Opioid modulation of neurotransmitters within the VP is hypothesized to play a role in its information processing functions.

Purpose of the Study:

  • To investigate how mu opioid receptor (microR) agonists modulate neurotransmitter transmission in the ventral pallidum.
  • To determine the impact of opioid modulation on VP neuronal responses to various afferent inputs.

Main Methods:

  • In vitro and in vivo electrophysiological recordings from rat VP neurons.
  • Microiontophoresis of opioid agonists and other transmitters.
  • Electrical stimulation of afferent pathways (prefrontal cortex, amygdala, nucleus accumbens, midbrain dopaminergic cells).

Related Experiment Videos

Main Results:

  • Opioid agonists hyperpolarized VP neurons and suppressed spontaneous firing.
  • Mu opioid receptor agonists enhanced signal-to-noise ratio for glutamatergic inputs from the prefrontal cortex and amygdala.
  • Mu opioid receptor agonists attenuated excitatory responses to substance P and inhibitory responses to GABA from the nucleus accumbens, as well as inhibitory responses to midbrain dopaminergic cell stimulation.

Conclusions:

  • Opioid transmission in the VP selectively gates afferent information, potentiating glutamatergic inputs while diminishing dopaminergic and GABAergic inputs.
  • In the context of opiate abuse, microR agonists in the VP may reduce the influence of reward pathways on cognitive and emotional processing, potentially contributing to drug craving.